There is abundant evidence that the serotonin (5-HT) system is modulating mood and several behavioural traits and that disturbances in the regulation of this system can be associated with severe behavioural malfunctions, as aggressive implusive and suicidal behaviour.
Disturbances in serotonergic (5-HT) neurotransmission are widely associated with impulsive, violent behaviour, depression and suicidality. 6 Evidence of a decreased serotonergic transmission in depression derives from the clinical observation that symptoms are relieved by drugs that either block 5-HT reuptake and metabolism or otherwise potentiate serotonergic activity. 7 Especially an inverse correlation between impulsive, externally directed aggressive behaviour and the concentration of the main 5-HT metabolite 5-hydroxyindolacetic acid (5-HIAA) in cerebrospinal fluid 8 as well as postmortem results on decreased concentration of serotonin and 5-HIAA in the brainstem of suicide victims 9 were part of the hypothesis that decreased serotonin-related neurotransmission is linked to the pathophysiology of depression and suicide. 10 Postmortem studies reported on altered serotonin transporter in brain samples from persons committing suicide. 11 However, the results of radioligand binding studies have been inconsistent, most probably because of the different ligands used. 12, 13 Studies with peripheral models, eg decreased 5-HT concentration in platelets 14 or platelet paroxetine binding studies 15 completed the postmortem findings in patients with suicidality or violent behaviour. Suicide is a multiply determined act and suicidal behaviour might be triggered by several risk factors such as acute psychiatric illness, substance abuse, adverse life events or family crisis. 16 Additionally, there is mounting evidence that genetic factors may be included in the determinants of suicidal behaviour. Clinical studies, which revealed that the risk of suicidal behaviour is increased by the presence of familial suicidality, 16 are supported by recent molecular genetic studies on associations between suicidal behaviour and different molecular genetic variants, mainly within genes of the serotonergic system. Among them the less common U-allele of the trytophan hydroxylase gene, which is the rate limiting enzyme for serotonin biosynthesis, was associated with a lifetime history of suicidal attempts. 17 Although this finding is in contradiction to an earlier study, where the presence of the L-allele was associated with increased risk of suicidality, 18 these findings underline the impact of the serotonergic system in suicidal behaviour. Additionally, a variation in a tetranucleotide repeat polymorphism in the first intron of the tyrosine hydroxylase (TH) gene locus was associated with suicidal behaviour 19 as well. Non-replication studies of the initially positive results 20 could be explained by substantial ethnic differences or by the fact, that the impact of genetic factors on the vulnerability to suicidal behaviour might be rather small. However, since other complex personality traits such as neuroticism, anxiousness or extraversion are at least partly genetically determined, it is increasingly thought that genetic factors are not solely responsible but interrelate with several other risk factors for increased susceptibility to suicidality. 21 The human serotonin transporter (5HTT) gene has a biallelic functional polymorphism in its 5Ј regulatory region (5-HTTLPR), being composed of a 44-bp insertion (L-allele) or deletion (S-allele), which regulates the transcription of the 5-HT transporter.
2 Interestingly, the deletion was found to be associated with affective disorders, 22 severe alcohol dependence, 5 late onset Alzheimer's disease 6, 23 as well as with several personality traits such as anxiety, depression and impulsiveness. 6 Several negative or only weak positive findings 24, 25 have been interpreted as being indicative of an involve-Molecular Psychiatry ment of the serotonergic system at the level of symptoms rather than that of disorders. 25 Although suicide is a multi-factorial act, one might hypothesise that impulsive aggression might be one mayor symptom and thus the serotonergic function could be of crucial importance. Therefore we have investigated the biallelic 5-HTTLPR polymorphism in the DNA of 58 suicide victims (irrespective of psychiatric diagnosis; all Caucasians from southern Germany) and a population of 110 healthy Caucasian controls, recruited from the general population of the same area.
In our study the genotype and allelic distributions in healthy controls were similar to those described by Lesch and colleagues 6 for a large sample of a Caucasian population (Ͼ500 persons) and complied to the HardyWeinberg equilibrium (Table 1) . A significantly different allelic distribution was observed in the group of suicide victims, with a higher frequency of the S-allele (59%) than in the control group (41%; two-sided Fisher's Exact Test: P = 0.0019). More than 90% of the suicide victims were carriers of at least one short allele, whereas one third (33%) of the controls had no S-allele (two-sided Fisher's Exact Test; P = 0.0003). The decrease in L/L homozygotes in suicide victims was compensated with a significant increase in both L/S and S/S genotypes ( 2 = 13.189, d.f. = 2; P = 0.0014). Interestingly, 53 of the suicide victims had committed violent suicide (eg shooting, hanging), but only five were employing so called soft suicide methods. Three of these were homozygous for the L-allele, and two had at least one L-allele, but none was homozygous for the short allele. The excess of males (69%) among suicide victims is not the reason for the increased frequency of the S-allele, since in the control group no correlation between sex and alleles was found (
Although the investigated number of suicide victims is still low, our results suggest that the 5-HT-transporter promoter polymorphism may contribute not only to certain behavioural traits such as anxiety, depression and neuroticism, but also to violent suicide. Since this polymorphism is responsible for decreased expression of the transporter gene and decreased uptake of 5-HT, 26 this result is in good agreement with multiple findings of reduced paroxetine binding in postmortem brains of suicide victims and in platelets during depression or impulsive aggression in personality disorders. 15 A recent study on platelet serotonin uptake suggested that the affinity of 5-HT uptake protein may be decreased in patients who exhibited suicidal behaviour. 27 Our results further supplement earlier genetic studies which reported on altered serotonin synthesis in suicidal behaviour due to different allelic distribution of the TPH gene, 18 thus suggesting that more than one compartment of the serotonergic system might be involved in vulnerability to suicidal behaviour.
Further investigations have to figure out, if this increased frequency of the S-allele is restricted to patients who have committed violent suicide or if it may be a more generalised phenomenon in suicidal behaviour. Our results further suggest that the reduced 5-HT transporter function in platelets is linked to the general level of gene transcription and thus occurs in parallel in platelets and in brain. Since not only depression, the main disorder with the risk of suicidality, but also many other psychiatric disturbances are associated with increased suicides, a better understanding of the underlying pathophysiological process could be a step forward in recognition of patients being under risk and treatment.
Methods

Sample
Fifty-eight suicide victims (40 males, 18 females; mean age 46 ± 16 years) from the same area were included. Prerequisites for inclusion in the latter group were proven suicide (exclusion of forensically doubtful or unclear cases), definite evidence of intent, including choice of an assumable reliable method (ie shooting, jumping from a great height, hanging, lying before oncoming trains, etc) and exclusion of cases with appellative motivational characteristics and settings. Blood for DNA analyses of the latter group was taken during post-mortem examination of the victims.
One hundred and ten healthy, unrelated Caucasians were recruited from the general population in Southern Germany (54 males, 56 females, mean age 47 ± 12 years) as a control group. All probands were screened psychiatrically using the OPCRIT 3.3 checklist. 28 Probands with a known history of psychiatric disorders, including drug abuse, in the indexprobands themselves and their first-degree relatives were excluded from the study.
Genotyping
A blood sample was obtained from each individual (written informed consent from controls). Genomic DNA was extracted from leukocytes or whole blood (suicide victims) according to standard procedures. Polymerase chain reaction (PCR) amplification was performed using the primers described by Cook et al. 29 PCR products were separated on a 3% agarose gel (FMC NuSieve 3:1, from Biozym, Hess Oldendorf, Germany) and visualized by ethidium bromide staining. All laboratory procedures were carried out blind to the case-control status.
Statistical analysis
Statistical analyses were carried out using the SSPS (Statistical Package for Social Science) Software, Version 7.5. The genotype distribution and the presence of the Hardy-Weinberg equilibrium were tested by the 2 test for goodness-of-fit. Frequency of the short allele was compared between suicide victims and the control group by using the two-sided Fisher's Exact Test.
